GLYCOMIMETICS INC's ticker is GLYC and the CUSIP is 38000Q102. A total of 40 filers reported holding GLYCOMIMETICS INC in Q2 2024. The put-call ratio across all filers is 0.08 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $203,649 | -90.7% | 723,184 | -1.3% | 0.00% | – |
Q1 2024 | $2,197,701 | +26.7% | 732,567 | -0.3% | 0.00% | – |
Q4 2023 | $1,734,560 | +57.4% | 734,983 | +0.0% | 0.00% | – |
Q3 2023 | $1,102,058 | -19.2% | 734,704 | -6.3% | 0.00% | – |
Q2 2023 | $1,363,994 | +66.8% | 783,905 | +20.8% | 0.00% | – |
Q1 2023 | $817,633 | -64.4% | 648,915 | -14.5% | 0.00% | – |
Q4 2022 | $2,298,849 | +443.5% | 758,696 | -0.9% | 0.00% | – |
Q3 2022 | $423,000 | -7.8% | 765,885 | -0.3% | 0.00% | – |
Q2 2022 | $459,000 | -53.6% | 768,333 | -11.5% | 0.00% | – |
Q1 2022 | $990,000 | -21.2% | 868,237 | -0.5% | 0.00% | – |
Q4 2021 | $1,257,000 | -34.4% | 872,858 | -0.3% | 0.00% | – |
Q3 2021 | $1,917,000 | -6.8% | 875,151 | -1.2% | 0.00% | – |
Q2 2021 | $2,057,000 | -75.8% | 886,148 | -68.6% | 0.00% | – |
Q1 2021 | $8,499,000 | -13.6% | 2,823,587 | +7.9% | 0.00% | – |
Q4 2020 | $9,839,000 | +9.2% | 2,616,477 | -10.9% | 0.00% | – |
Q3 2020 | $9,010,000 | -19.4% | 2,934,925 | -1.3% | 0.00% | – |
Q2 2020 | $11,179,000 | +76.8% | 2,973,315 | +7.2% | 0.00% | – |
Q1 2020 | $6,322,000 | -57.8% | 2,772,420 | -2.0% | 0.00% | -100.0% |
Q4 2019 | $14,964,000 | +18.5% | 2,828,511 | -3.5% | 0.00% | 0.0% |
Q3 2019 | $12,628,000 | -63.0% | 2,929,850 | +2.3% | 0.00% | 0.0% |
Q2 2019 | $34,147,000 | -5.1% | 2,864,664 | -0.8% | 0.00% | -50.0% |
Q1 2019 | $35,970,000 | +33.5% | 2,886,908 | +1.5% | 0.00% | +100.0% |
Q4 2018 | $26,941,000 | -34.4% | 2,844,893 | -0.3% | 0.00% | -50.0% |
Q3 2018 | $41,090,000 | -9.1% | 2,853,504 | +1.8% | 0.00% | 0.0% |
Q2 2018 | $45,214,000 | +134.9% | 2,803,151 | +136.4% | 0.00% | +100.0% |
Q1 2018 | $19,245,000 | +15.6% | 1,185,776 | +19.5% | 0.00% | 0.0% |
Q4 2017 | $16,655,000 | +126.9% | 991,948 | +89.1% | 0.00% | – |
Q3 2017 | $7,340,000 | +35.7% | 524,610 | +8.2% | 0.00% | – |
Q2 2017 | $5,409,000 | +93.8% | 484,759 | -5.7% | 0.00% | – |
Q1 2017 | $2,791,000 | +92933.3% | 513,858 | +109933.8% | 0.00% | – |
Q4 2016 | $3,000 | 0.0% | 467 | 0.0% | 0.00% | – |
Q3 2016 | $3,000 | 0.0% | 467 | 0.0% | 0.00% | – |
Q2 2016 | $3,000 | – | 467 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BVF INC/IL | 2,426,282 | $17,348,000 | 3.27% |
NEA Management Company, LLC | 8,584,128 | $61,377,000 | 2.76% |
SPHERA FUNDS MANAGEMENT LTD. | 718,080 | $5,134,000 | 0.84% |
WALL STREET ASSOCIATES | 150,000 | $1,072,000 | 0.36% |
Cormorant Asset Management, LP | 287,031 | $2,052,000 | 0.23% |
Candriam S.C.A. | 160,000 | $1,144,000 | 0.03% |
PRENTISS SMITH & CO INC | 7,000 | $50,000 | 0.03% |
Baker Brothers Advisors | 381,235 | $2,726,000 | 0.02% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 109,764 | $785,000 | 0.01% |
WELLINGTON MANAGEMENT GROUP LLP | 2,762,807 | $19,754,000 | 0.01% |